Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Ahmedov (Samarkand, Uzbekistan). Immunostimulating therapy in treatment of Community-acquired pneumonia. 4106

Member's Comments

No comment yet.

Related content which might interest you: Community-acquired pneumonia: severity and antibiotic treatments Source: ERS Course 2018 - Respiratory Infections Year: 2018 Community-acquired pneumonia Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Community-acquired pneumonia Source: International Congress 2019 – Part I: Prevention and management of respiratory infections in primary care. Year: 2019 Community-acquired pneumonia Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Ertapenem therapy for community-acquired pneumonia in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 638s Year: 2005 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Community-acquired pneumonia in children Source: Annual Congress 2012 - PG15 Common respiratory infections in childhood: current guidelines and controversies Year: 2012 Cost-effectiveness of full-course oral levofloxacin in severe community-acquired pneumonia Source: Eur Respir J 2004; 24 : 644-648 Year: 2004 Community-acquired pneumonia: treatment failure and complications Source: ERS Course 2018 - Respiratory Infections Year: 2018 The approach to antibiotic treatment in community-acquired pneumonia Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia Year: 2008 Community-acquired pneumonia in younger patients is an entity on its own Source: Eur Respir J 2012; 39: 1156-1161 Year: 2012 Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Community-acquired pneumonia outbreaks control with azithromycin Source: Eur Respir J 2003; 22: Suppl. 45, 148s Year: 2003 Hospital-acquired pneumonia in patients receiving immunosuppressive therapy Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Community-acquired pneumonia in the elderly requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004 Are corticosteroids useful in community-acquired pneumonia? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006